Douglas J Jolly
4PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jul 22, 2024
Therapeutic activity of retroviral replicating vector-mediated gene therapy in combination with anti-PD-1 antibody in a murine pancreatic cancer model.Hiroki Niwa, Toru Nakamura, Hiroki Kushiya
|Dec 11, 2022
Retroviral Replicating Vector Toca 511 (Vocimagene Amiretrorepvec) for Prodrug Activator Gene Therapy of Lung Cancer.Hiroki Kushiya, Kei Hiraoka, Tomohiro Suzuki
|Aug 21, 2020
Molecular and Immunologic Signatures are Related to Clinical Benefit from Treatment with Vocimagene Amiretrorepvec (Toca 511) and 5-Fluorocytosine (Toca FC) in Patients with Glioma.William P Accomando, Aliz R Rao, Daniel J Hogan
|Jun 28, 2018
Molecular Analyses Support the Safety and Activity of Retroviral Replicating Vector Toca 511 in Patients.Daniel J Hogan, Jay-Jiguang Zhu, Oscar R Diago
Pageof 1
Frequent Collaborators
2 joint publications
Kazuho Inoko
2 joint publications
Noriyuki Kasahara
1 joint publications
Aliz R Rao
1 joint publications
Aki Nakao
1 joint publications
Ash A Alizadeh
1 joint publications
Maximilian Diehn
1 joint publications
Hiroki Kushiya
1 joint publications
Kei Hiraoka
1 joint publications
Hiroki Niwa
1 joint publications
Toru Nakamura
